Cogent Biosciences Advances Precision Medicine with New Drug Application Submission Cogent Biosciences, a biotechnology company dedicated to developing precision therapies for genetically defined diseases, announced today that it has submitted a key regulatory document for its latest therapeutic candidate. The submission marks a significant milestone in Cogent’s mission to bring targeted treatments to patients who…